Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspiration Hlt Regulatory News (IHC)

Share Price Information for Inspiration Hlt (IHC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.75
Bid: 16.50
Ask: 17.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.03%)
Open: 16.75
High: 16.75
Low: 16.75
Prev. Close: 16.75
IHC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Project Wave- IRAS submission

8 Sep 2020 07:00

RNS Number : 2736Y
Inspiration Healthcare Group PLC
08 September 2020
 

Inspiration Healthcare Group plc

 ("Inspiration Healthcare", the "Company" or the "Group")

 

Project WAVE - IRAS submission

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company is pleased to announce that it has submitted an application through the Integrated Research Approval System (IRAS) for trials to begin for the respiratory device it has designed for use in neonatal intensive care known as Project WAVE. The technology for Project WAVE was acquired by Inspiration Healthcare under licence in 2018 from a leading U.S. West Coast University and was granted a patent by the U.S. Patent Office as was announced on 25 March 2020.

 

The IRAS submission requests permission for the trial to begin at the Trevor Mann Baby Unit, Brighton & Sussex University Hospital (Royal Sussex). The application will be reviewed by The Medicines and Healthcare products Regulatory Agency (MRHA), Research Ethics Committee (REC) and Health Research Authority (HRA) to allow a non-C.E. marked device to be used under trial conditions.

 

Project WAVE received a grant towards the cost of this trial under the Med Tech Trials Innovation Support Grant scheme (MTT-ISG), awarded on 11 June 2020 by the Academic Health Science Networks (AHSN). The MTT-ISG grant is funded by the European Regional Development Fund (ERDF) who will contribute up to 50% (£50,000 maximum) towards the costs of this trial.

 

Neil Campbell, Chief Executive Officer, commented: "We are pleased to have submitted this application and moving the project on to the next phase. The Project WAVE device we have developed incorporates the latest findings in neonatal respiration from a leading U.S. West Coast University with Inspiration Healthcare's experience and knowledge in designing and manufacturing neonatal devices which improve medical outcomes. Once our submission gets the green light, which we expect in a few months, we look forward to working with the team at the Royal Sussex and getting the project one step closer to fruition."

 

 

 

Enquiries:

 

Inspiration Healthcare Group plc

Neil Campbell, Chief Executive Officer

Jon Ballard, Chief Financial Officer

Tel: 01455 840555

 

Nominated Adviser & Broker

Cenkos Securities plc

Mark Connelly

Stephen Keys

Cameron MacRitchie

Tel: 0207 397 8900

 

Cadogan PR

Alex Walters

alex.walters@cadoganpr.com

Tel: 07771 713608

 

 

About Inspiration Healthcare http://www.inspiration-healthcare.com

 

Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high-quality, innovative products to patients around the world which help to improve patient outcomes, and it actively invests in innovative product opportunities and disruptive technologies.

Through investment in research and development the Company has six key own-brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has a range of products for maintaining normothermia pre- during and post-surgery.

In September 2019, the Company acquired Vio Holdings a designer, manufacturer and supplier of single-use respiratory products and sterile medical consumables for £4 million and in June 2020 the Company acquired SLE, a leading global provider of neonatal ventilation products for £18 million.   Over 90% of SLE's revenues are generated from sales outside of the UK with a significant proportion of these in the Asia Pacific and the Middle East. When combined, the Group generates approximately 60 per cent. of its revenue from exports.

With product availability extending to over 50 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.

In the .K.U.K. and Ireland, the Company has a direct sales team selling Inspiration Healthcare Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Private Policy.
 
END
 
 
NRAZZGGLVNVGGZM
Date   Source Headline
7th Jul 20209:04 amRNSDirector/PDMR Dealings
7th Jul 20209:00 amRNSCompletion of Fundraising and Acquisition
7th Jul 20207:00 amRNSBoard Changes
6th Jul 20201:08 pmRNSResults of General Meeting & Open Offer
26th Jun 202012:10 pmRNSResult of AGM
26th Jun 20207:00 amRNSAppointment of CFO
26th Jun 20207:00 amRNSAGM Statement
22nd Jun 20209:40 amRNSTR1 Notification
19th Jun 20208:17 amRNSAcquisition, Placing, Open Offer and Notice of GM
18th Jun 20208:01 amRNSPDMR Dealing
16th Jun 20207:00 amRNSIssue of shares & total voting rights
15th Jun 20207:00 amRNSUpdate on Ventilator Delivery
11th Jun 20207:00 amRNSProject Wave awarded Innovation Support Grant
1st Jun 20207:00 amRNSNotice of AGM
6th May 20207:00 amRNSTrading Update
1st May 20207:00 amRNSNHS Orders Update
24th Apr 20207:00 amRNSDistribution agreement for AIHL test
24th Apr 20207:00 amRNSDistribution agreement for AIHL test
21st Apr 202011:00 amRNSReplacement - Final Results
21st Apr 20207:00 amRNSFinal Results
15th Apr 20202:01 pmRNSPrice Monitoring Extension
8th Apr 20207:36 amRNSPatents granted for FirstBreath™ breathing system
30th Mar 20204:29 pmRNSGrant of Options
25th Mar 20207:00 amRNSPatent granted for Project Wave
24th Mar 202011:08 amRNSTR1 Notification
20th Mar 20207:00 amRNSFurther Significant NHS Orders received
16th Mar 20207:00 amRNS£1.25 million NHS Order
26th Feb 20207:00 amRNSDirectorate Change
21st Feb 202012:59 pmRNSTR1 Notification
21st Feb 202010:05 amRNSTR1 Notification
20th Feb 20207:00 amRNSTrading Update
27th Jan 20207:00 amRNSGrowth & Innovation Forum 2020 and Arab Health
21st Jan 20207:00 amRNSEC certificates extended to May 2024
20th Jan 20207:00 amRNSSri Lankan Ministry of Health Order
9th Jan 202012:55 pmRNSTR1 Notification
7th Jan 20201:01 pmRNSTR1 Notification
31st Dec 20197:00 amRNSNPXe Files Chapter 11 to implement Asset Sale
30th Oct 20197:00 amRNSCosyTherm2 Launch and Investor Conference
2nd Oct 20197:00 amRNSInterim Results
26th Sep 201910:35 amRNSHolding(s) in Company
26th Sep 201910:32 amRNSHolding(s) in Company
25th Sep 20193:27 pmRNSHolding(s) in Company
24th Sep 20191:33 pmRNSHolding(s) in Company
24th Sep 201910:20 amRNSHolding(s) in Company
24th Sep 201910:17 amRNSHolding(s) in Company
24th Sep 201910:14 amRNSHolding(s) in Company
24th Sep 201910:11 amRNSHolding(s) in Company
24th Sep 201910:09 amRNSDirector/PDMR Shareholding
23rd Sep 20193:42 pmRNSResult of General Meeting
12th Sep 20197:00 amRNSNotice of Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.